Pharmaceutical Executive November 21, 2023
Nicholas Saraceno

IQVIA report explores why these shortages are increasing, and how they can be mitigated.

Drug shortages are an issue that continue to grow in news coverage, due to their impact on patient care and public health. Data suggests that the amount of drug shortages in the US is increasing as more shortages continue to be reported than resolved. As a report by IQVIA titled Drug Shortages in the US 2023: A Closer Look at Volume and Price Dynamics1suggests, stakeholders have suggested various tactics to mitigate shortages, including prioritizing essential medicines, stockpiling, and making changes to reimbursement or statutory rebates. Shortages appear to be driven by a variety of causes that need to be better understood, as they may impact which...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech, Supply Chain, Survey / Study, Technology, Trends
Merck takes a slim lead in oncologists' perceptions amid a 'fiercely competitive' environment
Breaking down barriers for health system specialty pharmacies
Leqembi gets closer to being offered as an injection
Novo Holdings buys stake in life sciences tools company; BioMarin lays off 170
Walgreens to offer its own cheaper version of opioid overdose reversal drug naloxone

Share This Article